Trials / Completed
CompletedNCT02440022
Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae
A Prospective, Global, Multicenter, Randomized, Controlled Study Comparing Lutonix® 035 AV Drug Coated Balloon PTA Catheter vs. Standard Balloon PTA Catheter for the Treatment of Dysfunctional AV Fistulae
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 285 (actual)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, global, multicenter, randomized, controlled study is designed to evaluate the safety and effectiveness of the Lutonix 035 AV Drug Coated Balloon PTA Catheter compared to a standard PTA Catheter in treating subjects presenting with clinical and hemodynamic abnormalities in native arteriovenous (AV) fistulae located in the upper extremity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Lutonix DCB | |
| DEVICE | Standard Balloon Angioplasty Catheter | |
| PROCEDURE | Percutaneous Transluminal Angiography | Percutaneous transluminal angioplasty (PTA) is a procedure that can open up a blocked blood vessel using a small, flexible plastic tube, or catheter, with a "balloon" at the end of it. When the tube is in place, it inflates to open the blood vessel, or artery, so that normal blood flow is restored. |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2016-09-01
- Completion
- 2018-06-01
- First posted
- 2015-05-12
- Last updated
- 2020-05-06
- Results posted
- 2020-05-06
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02440022. Inclusion in this directory is not an endorsement.